Skip to Main Content
  • Yale New Haven Transplantation Center
    Danbury Hospital
    24 Hospital Avenue
    Danbury, CT 06810
  • Yale Transplant & Immunology Program
    Greenwich Hospital
    5 Perryridge Rd
    Greenwich, CT 06830
  • Yale New Haven Transplantation Center
    Yale Physicians Building
    800 Howard Avenue, Fl 4th floor
    New Haven, CT 06519
  • Yale Transplantation Center; Long Ridge Medical Center
    260 Long Ridge Road
    Stamford, CT 06902

Michael Schilsky, MD

Hepatology
Telehealth is available
Learn more about telehealth
Patient type treated
Child, Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Internal Medicine and Gastroenterology

Biography

Michael Schilsky, MD, is the medical director of Adult Liver Transplant at Yale-New Haven Transplantation Center. He is an internationally recognized expert in Wilson disease, a rare genetic disorder in which excessive amounts of copper accumulate in the body.

Dr. Schilsky says he was drawn to the study and treatment of Wilson disease because of its complexity, and he is optimistic about the growing promise of new treatments that can help patients with this difficult medical condition. “Wilson disease can be hard to diagnose as it can present with a constellation of symptoms, but once considered we have great tools now to establish the diagnosis and treat this disorder,” he says. “The future is very bright. We hope to have a cure someday, perhaps by genetic therapy. In the meantime, new innovations and medications being tested in clinical trials are truly helping patients.”

An advisor to the Wilson Disease Association, Dr. Schilsky helped write guidelines for the diagnosis and treatment of the disorder for both the American Association for the Study of Liver Disease and the European Association for Liver Disease. Here in the Northeast, Yale is the only Center of Excellence designated by the Wilson Disease Association. We are one of a limited number of sites worldwide to participate in a clinical trial for a promising new therapy for Wilson disease, an oral medication known as WTX101.

Left untreated, Wilson disease can cause advanced liver disease or acute liver failure. Dr. Schilsky specializes in managing these challenging cases, including those caused by other metabolic liver diseases. If a liver transplant is required (these are performed at Yale-New Haven Hospital) Dr. Schilsky cares for patients both before and after the surgery. Dr. Schilsky is also a professor of medicine (digestive diseases) and surgery (transplant and immunology) at Yale School of Medicine. 

Titles

  • Professor of Medicine
  • Medical Director, Adult Liver Transplant at Yale-New Haven Transplantation Center

Education & Training

  • Fellow
    Albert Einstein College of Medicine (1989)
  • Fellow
    Albert Einstein College of Medicine (1987)
  • Resident
    Bronx Municipal Hospital Center/Albert Einstein College of Medicine (1985)
  • MD
    University of Chicago Pritzker School of Medicine (1982)
  • BS
    SUNY at Stonybrook (1978)

Additional Information

Biography

Michael Schilsky, MD, is the medical director of Adult Liver Transplant at Yale-New Haven Transplantation Center. He is an internationally recognized expert in Wilson disease, a rare genetic disorder in which excessive amounts of copper accumulate in the body.

Dr. Schilsky says he was drawn to the study and treatment of Wilson disease because of its complexity, and he is optimistic about the growing promise of new treatments that can help patients with this difficult medical condition. “Wilson disease can be hard to diagnose as it can present with a constellation of symptoms, but once considered we have great tools now to establish the diagnosis and treat this disorder,” he says. “The future is very bright. We hope to have a cure someday, perhaps by genetic therapy. In the meantime, new innovations and medications being tested in clinical trials are truly helping patients.”

An advisor to the Wilson Disease Association, Dr. Schilsky helped write guidelines for the diagnosis and treatment of the disorder for both the American Association for the Study of Liver Disease and the European Association for Liver Disease. Here in the Northeast, Yale is the only Center of Excellence designated by the Wilson Disease Association. We are one of a limited number of sites worldwide to participate in a clinical trial for a promising new therapy for Wilson disease, an oral medication known as WTX101.

Left untreated, Wilson disease can cause advanced liver disease or acute liver failure. Dr. Schilsky specializes in managing these challenging cases, including those caused by other metabolic liver diseases. If a liver transplant is required (these are performed at Yale-New Haven Hospital) Dr. Schilsky cares for patients both before and after the surgery. Dr. Schilsky is also a professor of medicine (digestive diseases) and surgery (transplant and immunology) at Yale School of Medicine. 

Titles

  • Professor of Medicine
  • Medical Director, Adult Liver Transplant at Yale-New Haven Transplantation Center

Education & Training

  • Fellow
    Albert Einstein College of Medicine (1989)
  • Fellow
    Albert Einstein College of Medicine (1987)
  • Resident
    Bronx Municipal Hospital Center/Albert Einstein College of Medicine (1985)
  • MD
    University of Chicago Pritzker School of Medicine (1982)
  • BS
    SUNY at Stonybrook (1978)

Additional Information

  • Yale New Haven Transplantation Center
    Danbury Hospital
    24 Hospital Avenue
    Danbury, CT 06810
  • Yale Transplant & Immunology Program
    Greenwich Hospital
    5 Perryridge Rd
    Greenwich, CT 06830
  • Yale New Haven Transplantation Center
    Yale Physicians Building
    800 Howard Avenue, Fl 4th floor
    New Haven, CT 06519
  • Yale Transplantation Center; Long Ridge Medical Center
    260 Long Ridge Road
    Stamford, CT 06902